Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Approves St. Jude’s Quadripolar CRT-D Device Following Delay

This article was originally published in The Gray Sheet

Executive Summary

The approval is significant as it marks the entry of the first quadripolar pacing system into the U.S. market. But St. Jude may not get as big of a positive gain from the product as previously expected, analysts suggest.

You may also be interested in...



Boston Scientific Will Lean On Quadripolar, S-ICD To Revive Sagging U.S. CRM Sales

Boston Scientific reported disappointing first-quarter results for its cardiac rhythm management division, mostly due to price erosion in the U.S and the lack of a quadripolar CRT-D device. But the firm argues that the new S-ICD and forthcoming quadripolar CRT-D products may help turn the business around soon.

St. Jude Outlines Strategy To Revive Pacemaker Business

St. Jude Medical’s pacemaker revenue dropped 12 percent year-over-year in the first quarter, but the firm says it has several products in the pipeline that could help it regain pacemaker market share in Europe and Japan.

New Products In Brief

Medtronic launches quadripolar CRT leads in Europe, more product news.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT030777

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel